Quantcast

Latest Clinical research Stories

2014-08-25 16:25:47

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Tremor Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2312347/Tremor-Global-Clinical-Trials-Review-H2-2014.html Tremor Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Tremor Global Clinical Trials Review, H2, 2014" provides data on the Tremor clinical trial scenario. This report provides elemental information and data relating to...

2014-08-25 16:25:29

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Traumatic Pain Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2312345/Traumatic-Pain-Global-Clinical-Trials-Review-H2-2014.html Traumatic Pain Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Traumatic Pain Global Clinical Trials Review, H2, 2014" provides data on the Traumatic Pain clinical trial scenario. This report provides...

2014-08-25 08:27:22

ENGLEWOOD, Colo., Aug. 25, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today is issuing this response to the most commonly asked questions in regards to the STEP study and clarify its plan for moving forward with Ampion(TM) for osteoarthritis of the knee. http://photos.prnewswire.com/prnvar/20120516/MM09116LOGO Letter to Ampio Shareholders from Michael Macaluso, Chairman & CEO and David Bar-Or, MD, Chief Scientific Officer The STEP study of Ampion(TM)...

2014-08-25 08:27:16

FALLS CHURCH, Va., Aug. 25, 2014 /PRNewswire-iReach/ -- 9(th) Annual FDA Inspections Summit **Presented by FDAnews** Oct. 22-24, 2014 - Bethesda, MD www.fdanews.com/9thFDAInspectionsSummit Photo - http://photos.prnewswire.com/prnh/20140822/138921 What's the state of FDA's Quality Metrics Initiative? When will drug and devicemakers have to start collecting data? What will they have to track? And where does the agency stand on the reorganization of its inspectional operations? What will that...

2014-08-24 23:02:07

MarketOptimizer.org adds “Trigeminal Neuralgia Global Clinical Trials Review, H2, 2014” to its store. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Dallas, Texas (PRWEB) August 24, 2014 Clinical trial report, “Trigeminal Neuralgia Global Clinical Trials Review, H2, 2014″ provides data on the Trigeminal Neuralgia clinical trial scenario. This report provides elemental information and data relating to...

2014-08-23 23:01:03

MarketOptimizer.org adds “Cardiomyopathy Global Clinical Trials Review, H2, 2014” to its store. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Dallas, Texas (PRWEB) August 23, 2014 Cardiomyopathy (heart muscle disease) is the measurable deterioration of the function of the myocardium (the heart muscle) for any reason, usually leading to heart failure; common symptoms are dyspnea (breathlessness) and...

2014-08-22 23:08:21

For generic drugmakers, Oct. 1 is crunch time and is the date after which all ANDA amendment and prior-approval supplement applications must meet new performance goals under the Generic Drug User Fee Amendments (GDUFA) of 2012. Joan Janulis, a Hatch-Waxman pro and all-around expert on FDA regulation in the generic drug industry, will help attendees read between the lines of the GDUFA performance metrics, associated guidance documents and MAPPs, and provide a roadmap to the post-GDUFA...

2014-08-22 23:07:45

On August 19, the FDA announced that certain lots of the Diamondback 360 Peripheral Orbital Atherectomy Systems, by Cardiovascular Systems, are recalled because they may contain sheath that can fracture during use. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 22, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest...

2014-08-21 23:14:15

In four hours, John Avellanet delivers proven, practical techniques for fast, flexible, flawless inspectional handling and response. Attendees will leave the session with a complete inspection SOP and an observation closure matrix, able to prove to an investigator they’re in a “state-of-control” and, if the worst happens, go from 483 observation to a coveted Untitled Letter without ever triggering a Warning Letter. Falls Church, VA (PRWEB) August 21, 2014 Flawless FDA Inspection...

2014-08-21 23:07:34

Series of 1-Day, Global Events Focuses on Maximizing Patient-Centric Endpoints Philadelphia (PRWEB) August 21, 2014 ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today opened registration for the PROFICIENCY™ 2014 Regional Conference Series: Maximizing Product Value with Optimized Endpoints. The series of 1-day educational events enable biopharmaceutical developers to network with leading researchers as they participate...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related